Work

Crytanshinone Combined with MAPK Pathway Inhibitors Jointly Inhibits the Growth of BRAF-Mutated Melanoma by Inhibiting the Expression of Yamanaka Factors

Year: 2023

Type: preprint

Source: SSRN Electronic Journal

DOI: 10.2139/ssrn.4570480

Authors: Kun Zhao, Yi Duan, Xing Luo, Xinzhi Dai, Zhengli Zhou, Xue Wen, Huajun Tang, Johannes Haybaeck, Chonglin Yu, Zhihui Yang

Institutions: Southwest Medical University, Zunyi Medical University, Innsbruck Medical University

Language: English

Topic: Melanoma and MAPK Pathways

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: green

OpenAlex ID: W4386736342

Cites:

Cited by:

Related to: 10